Literature DB >> 22523258

Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia.

Jean-Marc Costa1, Françoise Botterel, Odile Cabaret, Françoise Foulet, Catherine Cordonnier, Stéphane Bretagne.   

Abstract

Circulating Pneumocystis jirovecii DNA and (1→3)-β-d-glucan determined in 70 serum samples from immunocompromised patients were compared to fungal load in bronchoalveolar lavage fluids assessed using quantitative polymerase chain reaction. Both serum biomarkers are influenced by pulmonary fungal load, which should be taken into account when diagnosing Pneumocystis infection.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22523258     DOI： 10.1093/cid/cis412

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.

Authors:  D Salerno; D Mushatt; L Myers; Y Zhuang; N de la Rua; E J Calderon; D A Welsh
Journal:  Respir Med       Date:  2014-11       Impact factor: 3.415

3.  Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia.

Authors:  Angel Moreno; David Epstein; Indre Budvytiene; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2022-04-07       Impact factor: 11.677

4.  Emerging invasive fungal diseases in transplantation.

Authors:  Perrine Parize; Blandine Rammaert; Olivier Lortholary
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

5.  Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.

Authors:  Michael J Linke; Alan Ashbaugh; Margaret S Collins; Keeley Lynch; Melanie T Cushion
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

Review 6.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

7.  Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients.

Authors:  Dong Wang; Yang Hu; Ting Li; Heng-Mo Rong; Zhao-Hui Tong
Journal:  Oncotarget       Date:  2017-05-20

8.  Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia.

Authors:  Nicolas Guigue; Alexandre Alanio; Jean Menotti; Nathalie De Castro; Samia Hamane; Olivier Peyrony; Jérôme LeGoff; Stéphane Bretagne
Journal:  Med Mycol       Date:  2014-12-30       Impact factor: 4.076

9.  Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients.

Authors:  Jianlei Ji; Qinghai Wang; Tao Huang; Ziyu Wang; Pingli He; Chen Guo; Weijia Xu; Yanwei Cao; Zhen Dong; Hongyang Wang
Journal:  Infect Drug Resist       Date:  2021-11-24       Impact factor: 4.003

10.  (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.

Authors:  Sandra K White; Robert L Schmidt; Brandon S Walker; Kimberly E Hanson
Journal:  Cochrane Database Syst Rev       Date:  2020-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.